57/100BKeurig Dr Pepper stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Keurig Dr Pepper is 38.86, 1.6% above the current price of 38.27. Their targets range from 37.00 to 42.00.
Of the 14 firms that rated Keurig Dr Pepper in the past 12 months, 9 rate it buy or strong buy, 5 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 37.00 to 42.00, with an average of 38.86.
| Buy | 9 | |
| Hold | 5 | |
| Sell | 0 |
12-month price target
| Highest target | 42.00 |
| Average target | 38.86 |
| Lowest target | 37.00 |
| Current price | 38.27 |
Keurig Dr Pepper price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Keurig Dr Pepper price target and rating?
How analysts rate Keurig Dr Pepper, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 14 firms rate it buy now, against 9 of 15 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Keurig Dr Pepper analyst upgrades, downgrades and price targets
The latest rating change came on 13 August 2026, when HSBC upgraded Keurig Dr Pepper from Hold to Buy. Its price target is 40.00, from 30.00. The most recent new target came from Morgan Stanley on 20 August 2026: 38.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 20 Aug 2026 | Morgan Stanley Dara Mohsenian | — | 38.00 | — | 31.06 |
| 13 Aug 2026 | HSBC | Upgraded · Hold → Buy | 30.00 → 40.00 | +33.3% | 29.56 |
| 10 Aug 2026 | Barclays | Reiterated · Overweight | 28.00 → 38.00 | +35.7% | 30.01 |
| 4 Aug 2026 | RBC Capital Nik Modi | — | 42.00 | — | 30.88 |
| 16 Jul 2026 | UBS Peter Grom | Reiterated · Buy | 34.00 → 38.00 | +11.8% | 31.05 |
| 8 Jul 2026 | Bernstein | — | 38.00 → 39.00 | +2.6% | 31.24 |
| 1 Jul 2026 | Wells Fargo | — | 35.00 → 37.00 | +5.7% | 32.73 |
| 25 Jun 2026 | Barclays | Upgraded · Equal Weight → Overweight | — | — | — |
| 11 Jun 2026 | Bernstein | — | 38.00 | — | 31.23 |
| 24 Apr 2026 | UBS | Reiterated · Buy | 36.00 → 34.00 | -5.6% | 28.85 |
| 24 Apr 2026 | Evercore ISI | Reiterated · In Line | 30.00 | — | 28.76 |
| 22 Apr 2026 | BNP Paribas | Upgraded · Underperform → Neutral | — | — | — |
| 14 Apr 2026 | Barclays | Reiterated · Equal Weight | 30.00 → 28.00 | -6.7% | 25.93 |
| 26 Feb 2026 | UBS Peter Grom | — | 35.00 → 36.00 | +2.9% | 30.49 |
| 17 Dec 2025 | Jefferies | Downgraded · Buy → Hold | — | — | — |
| 16 Dec 2025 | Jefferies Kaumil Gajrawala | — | 41.00 → 32.00 | -22.0% | 28.59 |
| 15 Dec 2025 | Piper Sandler Michael Lavery | Reiterated · Overweight | 35.00 → 38.00 | +8.6% | 29.50 |
| 15 Dec 2025 | Deutsche Bank | — | 32.00 | — | 29.50 |
Keurig Dr Pepper EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Keurig Dr Pepper's EPS to grow 21.4% a year until 2028, faster than over the last 5 years (10.5% a year) and the last 3 years (14.8%).
Analysts expect Keurig Dr Pepper's revenue to grow 22.8% a year until 2028, faster than over the last 5 years (7.4% a year) and the last 3 years (5.7%).
Revenue
EPS
Does Keurig Dr Pepper beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.6% off the result, either way, and their revenue estimate 1.7%, over the last 12 quarters.
- EPS beats
- 50 / 75
- Revenue beats
- 57 / 75
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +3.6%
- Since
- June 2008
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 3 Nov 2026 | 0.62 | 0.66 | +6.8% | 7.33B | 7.34B | +0.2% |
| Q2 FY2026 | 6 Aug 2026 | 0.54 | 0.57 | +6.1% | 7.23B | 7.31B | +1.1% |
| Q1 FY2026 | 23 Apr 2026 | 0.37 | 0.39 | +4.7% | 3.84B | 3.98B | +3.7% |
| Q4 FY2025 | 24 Feb 2026 | 0.59 | 0.60 | +1.9% | 4.36B | 4.50B | +3.2% |
| Q3 FY2025 | 27 Oct 2025 | 0.54 | 0.54 | +0.6% | 4.15B | 4.31B | +3.7% |
| Q2 FY2025 | 24 Jul 2025 | 0.49 | 0.49 | +1.0% | 4.14B | 4.16B | +0.6% |
| Q1 FY2025 | 24 Apr 2025 | 0.38 | 0.42 | +9.8% | 3.57B | 3.64B | +1.9% |
| Q4 FY2024 | 25 Feb 2025 | 0.57 | 0.58 | +1.6% | 4.01B | 4.07B | +1.5% |
| Q3 FY2024 | 24 Oct 2024 | 0.51 | 0.51 | 0.0% | 3.92B | 3.89B | -0.8% |
| Q2 FY2024 | 25 Jul 2024 | 0.45 | 0.45 | 0.0% | 3.91B | 3.92B | +0.2% |
| Q1 FY2024 | 25 Apr 2024 | 0.35 | 0.38 | +8.6% | 3.41B | 3.47B | +1.8% |
| Q4 FY2023 | 22 Feb 2024 | 0.54 | 0.55 | +1.9% | 3.91B | 3.87B | -1.2% |
Keurig Dr Pepper stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Keurig Dr Pepper's earnings keep growing at the 10.1% a year analysts expect to FY2028, it would earn about 3.31 a share in FY2030. At the P/E it has traded at over the last five years (18.3 to 35.3) that is 60.67 to 117.00 a share, or 90.68 at its average P/E of 27.4. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 2.30 | 42.06 | 62.87 | 81.12 |
| FY2027 | 2.53 | 46.39 | 69.34 | 89.47 |
| FY2028 | 2.73 | 50.06 | 74.83 | 96.55 |
| FY2029 (extrapolated) | 3.01 | 55.11 | 82.37 | 106.29 |
| FY2030 (extrapolated) | 3.31 | 60.67 | 90.68 | 117.00 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 10.1% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (18.3, 27.4, 35.3).
Is Keurig Dr Pepper stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Keurig Dr Pepper's P/E of 34.7 is near the top of its 5-year range (16.5 to 37.2, median 24.6). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 1.6 on expected growth against 2.4 on its median P/E and past five years' growth. Fair value is not a reliable guide for Keurig Dr Pepper: its earnings swing (EPS fell 32.3% in FY2024), so its usual P/E would mislead. Its forward P/E, on the consensus for FY2026, is 16.7.
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 34.66
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 24.64
- Five-year P/E range
- 16.5 – 37.2
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 16.65
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.44
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +1.6%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 64.525 | 127.9762Price 64.53185 | +98.3% | |
| 28.410 | 56.3234Price 28.4196 | +98.2% | |
| 153.725 | 297.58169Price 153.73471 | +93.6% | |
| 243.002 | 464.71205Price 243.00627 | +91.2% | |
| 160.085 | 305.52160Price 160.09396 | +90.8% | |
| 37.565 | 71.4258Price 37.57193 | +90.1% | |
| 160.240 | 300.28225Price 160.24375 | +87.4% |
Furthest below the fair value on each stock's page, updated every day.